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Abstract – The effects of subchronic exposure to copper (cu) on lipid peroxidation, hemato-biochemical parameters, and 
the possible protective role of flavonoids Quercetin and (-)-epicatechin were studied. Male Wistar albino rats were treated 
with cu (560 mg/l, p.o. as cucl2·2H2O for 5 weeks) and Quercetin and (-)-epicatechin (40 mg/kg BW each, i.p., every 
third day during the last 3 weeks) alone or in combination. cu increased the concentration of lipid peroxides, decreased 
the number of erythrocytes, hemoglobin and hematocrit values and increased the activities of aspartate aminotransferase, 
alanine aminotransferase and lactate dehydrogenase. coadministration of Quercetin and (-)-epicatechin with cu lowered 
the process of lipid peroxidation and restored examined hemato-biochemical parameters to control values. Our results 
indicate that cu induced oxidative damage in erythrocytes, which led to anemia, while Quercetin and (-)-epicatechin 
showed a protective effect on the hemato-biochemical processes in the blood of rats. 
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IntRODuctIOn
copper (cu) is an essential trace element involved in 
many processes responsible for normal growth and 
development, as an integral part of specialized cupro-
proteins, such as ceruloplasmin (cP), cytochrome c 
oxidase,  dopamine  β-hydroxylase,  superoxide  dis-
mutase and tyrosinase (Ferenci, 2004; Kodama and 
Fujisawa, 2009). However, the accumulation of cu in 
amounts that exceed the metabolic requirements of 
the organism or cu homeostasis disorders can lead 
to the manifestation of its toxic effects (Fuentealba 
and Aburto, 2003). It is well known that redox-active 
metals, such as cu, are capable of inducing oxidative 
stress by increasing the production of reactive oxy-
gen species (ROS) which causes peroxidative degra-
dation of polyunsaturated fatty acids in membrane 
lipids, and leads to the damage of biomolecules (Hal-
liwell and Gutteridge, 2007).
As a result of increased anthropogenic activi-
ties, heavy metals, including cu, are increasingly 
present in the environment. cu salts are widely used 
as algicides, fungicides and pesticides. Acute con-
sumption of high cu amounts in water by humans 
may cause irritation of the stomach, nausea, loss of 
appetite and dehydration (Araya et al., 2004). The 
chronic use of water with increased cu concentra-
tions may also represent a potential risk to sensi-
tive populations, such as children and individuals 1272 JelenA M. MlADenOvIć et Al.
with a genetic disorder of cu metabolism (Brewer, 
2000). Increased cu accumulation in humans oc-
curs mainly due to metabolic disorders of genetic 
origin, as in Wilson’s disease, which causes hepatitis 
and liver cirrhosis, and nervous system and kidney 
disorders (Brewer, 2000; Patil et al., 2013). In addi-
tion, an excess of cu adversely affects the cardio-
vascular system, leading to high blood pressure and 
promoting  atherosclerosis  (Iskra  and  Majewski, 
2000).
Quercetin (Qe) and (-)-epicatechin (ec) belong 
to a group of plant polyphenolic flavonoids present 
in the daily diet of humans. The main sources of Qe 
are apples, citrus fruits, broccoli, onion, berries, tea 
and red wine (nutrient Data, laboratory, 2011). ec 
is the most abundant flavonoid in green and black 
tea, cocoa products, red wine and berries (nutrient 
Data, laboratory, 2011). A diet rich in flavonoids can 
reduce blood pressure, the risk of cardiovascular dis-
ease, improves the liver antioxidant defense system 
and has a beneficial effect on symptoms of neuro-
degenerative disorders in Parkinson’s and Alzheim-
er’s disease (Middleton et al., 2000; Schroeter et al., 
2006; larson et al., 2012). Apart from plant sources, 
these flavonoids are components of supplements in 
an alternative therapy for the treatment of allergies, 
asthma, bacterial infections, arthritis, gout, eye dis-
orders, hypertension and neurodegenerative disor-
ders (larson et al., 2012).
Flavonoids exhibit a wide range of biological ac-
tivities, including anti-oxidative, anti-allergic, anti-
viral, neuroprotective and cancer inhibiting, in vitro 
or in animal tissues (verma et al., 1988; Deschner 
et al., 1991; Middleton et al., 2000; Ishisaka et al., 
2011). In recent years attention has been devoted 
to their antioxidant activity. Due to their structure, 
flavonoids exhibit the ability to chelate transition 
metal ions and to “capture” and neutralize free radi-
cals, acting as chain-breaking antioxidant (Bors et 
al., 1990). 
The aim of this study is to investigate the effects 
of cu and the protective capacity of these particular 
flavonoids, Qe and ec, on hematological and bio-
chemical parameters in the blood of rats subchroni-
cally exposed to cu in excess. 
MAteRIAlS AnD MetHODS
Chemicals
chemicals for this study were obtained from Sig-
ma-Aldrich chemie GmbH (Germany) and Merck 
(Darmstadt, Germany). Quercetin and (-)-epicate-
chin were purchased from Sigma-Aldrich chemie 
GmbH  (Germany).  Solutions  were  prepared  with 
double-distilled  water.  All  reagents  and  chemicals 
were of analytical grade or higher purity.
Experimental animals
The study included male adult Wistar albino rats, 8 
weeks old, weighing 230±20 g at the beginning of the 
experiment. The animals were maintained in indi-
vidual cages under standard laboratory conditions 
(temperature 22°c±2°c; 12 h light-dark cycle). The 
animals had unlimited access to drinking water or 
a solution of cucl2 and standard rodent laboratory 
diet.  The  concentration  of  cucl2 was  determined 
based on the oral median lethal dose for rats (lD50). 
The amount of water and solutions they drank was 
measured every third day. At the end of experimental 
period, the animals were anesthetized with ether and 
sacrificed by decapitation. The experimental proce-
dures were approved by the university ethics com-
mittee.
Experimental design
After a period of adaptation for one week prior to the 
experiment, the animals were randomly divided into 
4 groups, 7 animals per group: Group 1 (control) 
received saline (0.3 ml/kg BW); Group 2 (cu) was 
treated with copper (as cucl2·2H2O at a concentra-
tion of 560 mg/l, p.o.) via drinking water for 5 weeks; 
Group 3 (Qe+ec) was treated with intraperitoneal 
injections (i.p.) of quercetin coadministered with ep-
icatechin (40 mg Qe/kg BW + 40 mg ec/kg BW, in 
0.3 ml double-distilled water) every third day for the 
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tions were administered; Group 4 (cu+Qe+ec) was 
treated with copper (as cucl2·2H2O at a concentra-
tion of 560 mg/l, p.o.) via drinking water for 5 weeks, 
and with quercetin coadministered with epicatechin 
(40 mg Qe/kg BW + 40 mg ec/kg BW, in 0.3 ml 
double-distilled water) i.p., every third day for the 
last 3 weeks of the experiment. A total of seven injec-
tions were administered.
Analytical procedures
The animals were measured, anesthetized with ether 
and decapitated 24 h after the last injection. Blood 
samples were collected in K-eDtA tubes for hema-
tological analysis or in tubes without anticoagulants 
for  other  analyses.  Hematological  and  biochemi-
cal parameters were measured on the day of sacri-
fice. Hematological analysis included the number of 
erythrocytes (RBc), hemoglobin (Hb), hematocrit 
(Hct) values, as well as hematological indices (mean 
corpuscular volume (Mcv), mean corpuscular he-
moglobin  (McH),  mean  corpuscular  hemoglobin 
concentration  (McHc)  and  red  cell  distribution 
width (RDW)) in whole blood, and was performed 
by standard methods on an automated hematology 
analyzer (Horiba Medical ABx Micros 60, Japan). 
Measurements  of  biochemical  parameters,  se-
rum total protein (tP), albumin (Alb), and activi-
ties  of  aspartate  aminotransferase  (ASt),  alanine 
aminotransferase (Alt) and lactate dehydrogenase 
(lDH)  were  performed  on  BioSystem  BtS  330 
(Spain), and serum concentrations of ceruloplasmin 
(cP) was performed on a Roche Hitachi 911 (Swiss) 
analyzer.
to  measure  lipid  peroxidation  (lPO),  whole 
blood samples with eDtA were centrifuged at 1 000 
× g (+4°c) for 10 min and the plasma was removed. 
The erythrocytes were washed three times with an 
equal volume of cold saline (0.9 %, v/v). One millilit-
er of washed erythrocytes was lysed on ice in 3 ml of 
dH2O (4°c) for 30 min. lPO in the hemolysate was 
determined using the method described by Ohkawa 
et al. (1979), based on the reaction of lipid peroxida-
tion products (MDA-malondialdehydes) with thio-
barbituric acid (tBA) (tBARS analysis). Hemolysate 
samples were extracted with 28% trichloroacetic acid 
and centrifuged at 1 000 × g for 10 min. The color re-
action was carried out by adding 1% tBA and incu-
bation of the samples in a warm bath at 90°c for 15 
min. The absorbances were measured with a uv-vis 
Spectrophotometer  (JenWAy  6105,  Staffordshire, 
uK) and results were expressed in nmol MDA/ml 
erythrocytes, using a molar extinction coefficient for 
MDA of 1.56 × 105 M−1·cm−1.
Statistical analysis
All  data  were  evaluated  using  SPSS  for  Windows 
(version 13.0) software (SPSS Inc., chicago, Il, uSA). 
The results are expressed as mean ± standard error 
of the mean (SeM). comparisons were made using 
either factorial analysis of variance (AnOvA) with 
a post hoc Bonferroni/Dunnett’s multiple analysis or 
Kruskal-Wallis test (for comparison across several 
groups) and Mann-Whitney test (for comparison be-
tween two groups). Differences at p<0.05 were con-
sidered statistically significant.
ReSultS
The effects of treatment with cu and the flavonoids 
Qe and ec on average animal weight are shown in 
table 1. The animals in group 1 (control), as well as 
groups 3 (Qe+ec) and 4 (cu+Qe+ec) gained in 
body weight during the 5-week experiment, while in 
group 2 (cu) the body weight decreased significant-
ly. The average amount of cucl2 solution emptied in 
the experimental group 2 (22.0 ml/rats/day) and in 
group 4 (24.3 ml/rats/day), was significantly lower 
than the volume of tap water drunk by the control 
animals  (30.3  ml/rats/day)  throughout  the  expo-
sure (table 1). The calculated average intake of cu2+ 
per rat was about 5 mg/day. There was no mortal-
ity among the animals, despite a reduction in body 
weight that was due to the avoidance of water and 
food intake and probable dehydration.
A subchronic exposure to cu significantly de-
creased RBc counts, Hb and Hct values compared 
to the control (table 2). coadministration of Qe and 1274 JelenA M. MlADenOvIć et Al.
Table 1. Body weights and water consumption of control and treated groups of rats after 5 weeks of treatment.
experimental groups
control
(n=7)
cu
(n=7)
Qe+ec
(n=7)
cu+Qe+ec
(n=7)
Initial body weight (g) 238.7 ± 13.02 232.7 ± 17.8 230.0 ± 21.3 232.9 ± 19.9
Final body weight (g) 263.3 ± 18.8 215.3 ± 15.5* 265.7 ± 20.7** 255.7 ± 17.6
Water consumption (ml/rat/day) 30.3 ± 1.5 22.0 ± 1.6* 30.8 ± 1.1** 24.3 ± 1.6*
n: number of animals in the group; cu: copper; Qe: quercetin; ec: epicatechin. values are given as mean ± SD. *p<0.05, significantly different from con-
trol; **p<0.05, significantly different from cu group.
Table 2. changes in haematological parameters of control and treated groups of rats after 5 weeks of treatment.
experimental groups
Parameters
control
(n=7)
cu
(n=7)
Qe+ec
(n=7)
cu+Qe+ec
(n=7)
RBc (×1012/l) 6.32 ± 0.89 5.16 ± 0.77* 7.19 ± 0.42** 6.87 ± 0.35**
Hb (g/l) 135.3 ± 4.22 101.1 ± 4.27* 144.0 ± 7.79** 141.3 ± 6.8**
Hct (%) 38.41 ± 4.86 29.52 ± 4.46* 41.05 ± 2.51** 38.35 ± 2.89**
Mcv (fl)  59.21 ± 2.08 56.80 ± 1.91 57.03 ± 2.96 56.10 ± 1.83
McH (pg) 21.1 ± 2.11 19.7 ± 2.46 20.02 ± 1.24 20.57 ± 0.82
McHc (g/l) 352.75 ± 12.62 347.87 ± 12.27 350.83 ± 7.78 368.75 ± 16.07**
RDW (%) 14.83 ± 1.73 15.95 ± 0.88 14.73 ± 1.67** 13.73 ± 0.4**
n: number of animals in the group; cu: copper; Qe: quercetin; ec: epicatechin; RBc: red blood cell; Hb: haemoglobin; Hct: haemat-
ocrit; Mcv: mean corpuscular volume; McH: mean corpuscular haemoglobin; McHc: mean corpuscular haemoglobin concentration; 
RDW: red cell distribution width. values are given as mean ± SD. *p<0.05, significantly different from control; **p<0.05, significantly 
different from cu group.
Table 3. changes in biochemical parameters of control and treated groups of rats after 5 weeks of treatment.
experimental groups
Parameters
control
(n=7)
cu
(n=7)
Qe+ec
(n=7)
cu+Qe+ec
(n=7)
tP (g/l) 60.9 ± 2.6 59.0 ± 2.9 61.4 ± 3.5 60.3 ± 5.1
Alb (g/l) 12.7 ± 1.5 12.0 ± 1.4 12.8 ± 1.9 11.5 ± 1.8
cP (mg/l)  54.4 ± 10.7 37.9 ± 12.2* 45.7 ± 11.4 52.7 ± 12.1
ASt (u/l) 141.8 ± 14.7 216.2 ± 18.4* 147.2 ± 13.7** 138.8 ± 18.7**
Alt (u/l) 50.6 ± 6.3 70.1 ± 12.3* 55.2 ± 8.9 61.4 ± 18.1
lDH (u/l) 1084.7 ± 158.3 2012.2 ± 114.2* 1097.7 ± 81.8** 998.3 ± 142.9**
n: number of animals in the group; cu: copper; Qe: quercetin; ec: epicatechin; tP: total protein; Alb: albumin; ASt: aspartate amin-
otransferase; Alt: alanine aminotransferase; lDH: lactate dehydrogenase; cP: ceruloplasmine. values are given as mean ± SD. *p<0.05, 
significantly different from control; **p<0.05, significantly different from cu group.FlAvOnOIDS PROtect AGAInSt cu tOxIcIty 1275
ec with cu significantly increased the values of the 
examined parameters compared to the cu group. We 
noticed a slight a decrease in the values of the hema-
tological indices Mcv, McH and McHc in the cu 
group compared to the control. However, the McHc 
value  was  significantly  higher  in  the  cu+Qe+ec 
group compared to the cu group.
table 3 shows the effects of treatment on bio-
chemical parameters. exposure to cu led to a slight 
decrease of tP and Alb, and a significant decrease in 
cP serum level compared to the control. coadmin-
istration of Qe+ec with cu raised cP to the level of 
the control. 
The cu treatment caused a significant increase 
in the activities of ASt, Alt and lDH as compared 
to the control. coadministration of Qe+ec with cu 
reversed  these  changes  to  the  values  measured  in 
control.
The data in Fig. 1 show that subchronic treat-
ment with cu led to a significant increase in lPO in 
the rats’ erythrocytes when compared to the control. 
co-treatment of Qe+ec with cu restored the lPO 
level to nearly those measured in the control group.
DIScuSSIOn
Although cu is an essential element for a number of 
biological processes, prolonged exposure to elevated 
concentrations may have adverse effects (Fuentealba 
and Aburto, 2003). In this study, we investigated the 
effects of cu and the influence of the flavonoids Qe 
and ec on hematological and biochemical param-
eters in the blood of rats after subchronical exposure 
to cu in excess.
Our results show that in animals subchronically 
exposed to cu their body weight decreased, which 
can be a predictor of poor general health. The de-
crease  in  body  weight  may  indicate  an  excessive 
breakdown of tissue proteins. Similarly, the results 
of Bataineh et al. (1998) showed that long-term con-
sumption of cu salts causes growth disorders and 
weight loss in animals. On the other hand, animals 
co-treated with ec, Qe and cu continuously gained 
weight.
Fig. 1.  lPO values in erythrocytes of control and treated groups of rats after 5 weeks of treatment cu: copper; Qe: quercetin; ec: epi-
catechin. values are given as mean ± SD (n = 7); *p<0.05, significantly different from control; #p<0.05, significantly different from cu 
group.1276 JelenA M. MlADenOvIć et Al.
exposure to cu significantly decreased RBc, Hb 
and Hct and led to anemia. Similar results were ob-
tained in other studies on animals (Bozynski et al., 
2009; nikolic et al., 2013). The research of Fernandes 
et al. (1988) showed that the incubation of an eryth-
rocyte suspension with cu2+ causes lipid peroxidation 
and hemolysis as a consequence of oxyhemoglobin 
oxidation by cu. The erythrocytes are more suscep-
tible to oxidative damage than other cells because 
they are constantly exposed to ROS and their mem-
branes are rich in unsaturated fatty acids (clemens 
and Waller, 1987). It was found that toxic cu con-
centrations reduce deformability of erythrocytes and 
increase membrane permeability and osmotic fragil-
ity of cells, resulting in reduced erythrocyte survival 
(Adams et al., 1979). The observed reduced number 
of RBc, Hb and Hct after cu exposure in our study is 
probably due to the oxidative damage of erythrocytes 
and increased erythrocyte destruction.
coadministration  of  Qe+ec  with  cu  showed 
protective  effects  on  hematological  parameters.  In 
the study of chouhan et al. (2011), Qe exerted ben-
eficial  effect  on  hematological  parameters  in  rats 
treated with fluoride. Martinez et al. (2012) found 
that the presence of ec prevents protein oxidation 
and positively affects membrane fluidity and eryth-
rocyte  morphology,  thereby  preventing  hemolysis 
resulting  from  peroxidation.  These  results  suggest 
that the protective effects of Qe and ec are likely due 
to their ability to capture ROS and thereby prevent 
erythrocyte damage and hemolysis. 
Metabolic processes in rats exposed to cu were 
also affected, which is reflected in the disturbance 
of biochemical parameters. cP, a cuproprotein that 
is synthesized in the liver, is the major carrier of cu 
in the blood. Reduced levels of cP are typically as-
sociated with a reduced level of cu in the serum of 
patients with Wilson’s disease, but reduced cP with 
normal or increased levels of serum cu may suggest 
increased levels of cu not bound to cP (the so-called 
free  copper  or  non-ceruloplasmin-bound  copper) 
(Kodama and Fujisawa, 2009). An elevated level of 
cu in circulation may be the result of a sudden cu 
release from the hepatocytes, caused by liver damage 
or intoxication with cu (Patil et al., 2013). treatment 
with cu in the present study significantly decreased 
cP but did not lead to significant changes in the se-
rum level of cu (data not shown) as compared to the 
control, which may indicate the release of non-cer-
uloplasmin-bound cu from damaged hepatocytes. 
coadministration of Qe+ec with cu reversed the 
changes in protein levels and cP, suggesting protec-
tive effects of these flavonoids on hepatocytes. 
cu  treatment  increased  the  activities  of  ASt, 
Alt  and  lDH  in  the  serum.  transaminases  are 
widely distributed in tissues, while their concentra-
tions in the serum are low. Since the liver is the or-
gan of cu accumulation, these changes may indicate 
liver damage and, due to the distortion of functional 
integrity of hepatocyte cell membranes, the release 
of these enzymes in serum and their enhanced ac-
tivity. Increased transaminase (ASt and Alt) activi-
ties in serum serve as parameters in the diagnosis of 
hepatitis and hemolytic anemia in humans and also 
indicate  liver  damage  in  animal  (Fuentealba  and 
Aburto, 2003; Gaetke and chow, 2003). George and 
chandrakasan (1997) reported a significant increase 
in lDH activity in the serum of rats as a result of 
hepatic fibrosis.
Qe+ec administered alone did not cause sig-
nificant differences in the activities of these enzymes 
compared to the control group. However, coadmin-
istration of Qe+ec with cu decreased Alt and sig-
nificantly reduced ASt and lDH activities compared 
to the cu group. This is consistent with the results of 
other studies in which Qe inhibited the increase of 
ASt, Alt and lDH activities in serum by reducing 
the lPO in the liver (tokyol et al., 2006) and myocar-
dium of animals (Matouk et al., 2013; Milton et al., 
2013). These results indicate that Qe and ec are able 
to preserve the functional integrity of hepatocyte cell 
membranes and to prevent leakage of these enzymes 
into the blood.
cu  is  essential  for  numerous  biological  func-
tions,  including  the  synthesis  of  phospholipids  in 
cell membranes that maintains the integrity of the 
cell (Ferenci, 2004). However, as earlier studies have FlAvOnOIDS PROtect AGAInSt cu tOxIcIty 1277
shown, an excess of cu in rat diet may cause lPO and 
damage of the membrane (Dillard and tappel, 1984; 
Burkitt, 2001; Gaetke and chow, 2003). Fernandes et 
al. (1988) reported increased lPO after incubation of 
human erythrocyte suspension with cu2+ ions. The 
cu+ ion generated by the reduction of cu2+ in the 
presence of superoxide anion (O2
•-) catalyzes the for-
mation of hydroxyl radicals (•OH) that readily en-
ter into further reactions (Halliwell and Gutteridge, 
2007). O2
•-, •OH, or lipid peroxyl radicals can cause 
lPO, a decrease in membrane potential, and an in-
crease in permeability to H+ and other ions, which 
eventually leads to the release of contents from cells 
(Halliwell and Gutteridge, 2007). cu in our study 
significantly increased lPO in erythrocytes, indicat-
ing oxidative damage of cell membranes and the oc-
currence of oxidative stress in erythrocytes. 
Our  data  indicate  that  Qe+ec  inhibited  cu-
induced  lPO.  Previous  studies  have  shown  that 
flavonoids  can  block  lPO  due  to  their  structure 
that enables them to chelate metal ions or scavenge 
ROS as hydrogen- or electron-donating compounds 
(Middleton et al., 2000; Mira et al., 2002). They thus 
can be helpful in conditions and diseases caused by 
increased metal concentrations or in conditions that 
are the result of oxidative stress. Mira et al. (2002) 
showed that Qe and catechin chelate cu2+ ions, due 
to their hydroxyl groups with interaction probably 
between the 5-hydroxyl and 4-oxo groups. It has also 
been reported that catechins have an antioxidant ef-
fect on iron-induced lPO due to iron chelation (Sug-
ihara et al., 2001). 
lPO could be inhibited by ROS scavenging, and 
Qe as well as ec appears to be an extremely efficient 
radical scavenger (Middleton et al., 2000). The anti-
oxidant properties of Qe and ec may contribute to 
the improvement of cells’ antioxidant defense. Filipe 
et al. (2001) showed that Qe inhibited cu-induced 
lPO  in  human  plasma.  These  authors  have  also 
shown that there was a synergy of Qe with endog-
enous urate in antioxidant action against cu-induced 
lPO, and that the flavonoids were able to protect 
urate from oxidative degradation. Dietrich-Muszal-
ska et al. (2012) have shown that ec was more effec-
tive than Qe in reducing lPO in human plasma in 
vitro. In an in vitro study of Boadi et al. (2003), it was 
shown that in reducing lPO, combinations of flavo-
noids provide better antioxidant protection than the 
individual treatments. 
According to Bors et al. (1990), three structural 
group of flavonoids are responsible for metal chelat-
ing and radical scavenging: i) the O-dihydroxy struc-
ture in the B-ring, which is the radical target site for 
all flavonoids with a saturated c-2/c-3 bond; ii) the 
c-2/c-3 double bond in conjugation with a 4-oxo 
function, which is responsible for electron delocali-
zation from the B-ring; and iii) the additional pres-
ence of both 3- and 5-hydroxyl groups for strongest 
radical absorption.
Our  data  suggest  that  cu  in  excess  exerted 
prooxidant effects on hematological and biochemi-
cal  processes  in  the  blood  and  caused  oxidative 
damage in erythrocytes. treatment with Qe and ec 
could protect against oxidative damage in the blood 
of rats subchronically exposed to cu in excess. The 
cytoprotective role of Qe and ec can be ascribed to 
their ability to chelate the ions of transition metals 
and scavenge ROS. They managed to inhibit lPO, 
thus demonstrating a significant role in alleviating 
the manifestations of cu toxicity.
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